Aims and Scope

Oncology and Translational Medicine (OTM) is an international, open-access, peer-reviewed academic journal that aims to promote research in oncology and translational medicine as well as levels of service in clinical practice. It publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. OTM covers the types of Original research, Review articles, Consensus and Guideline, Perspectives, Letters to the Editor, Editorials, Commentary, Personage Column, Case Report, etc.

OTM is administered by Huazhong University of Science and Technology ( and is published by Wolters Kluwer Lippincott ( under the support of Tongji Hospital (, Tongji Medical College (, Huazhong University of Science and Technology and Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province (  

Supervised by 

Ministry of Education of the People's Republic of China

Administered by 

Tongji Medical College, Huazhong University of Science and Technology. 

Submission information

Manuscripts should be submitted to: Editorial Manager - Oncology and Translational Medicine (

Editors-in-Chief: Xiaoping Chen, William C. Chapman, Renzo Dionigi

CN: 42-1865/R

ISSN: 2095-9621

Online ISSN: 2995-5858

Frequency: 6 Issues per year

Mailing address

Editorial office of Oncology and Translational Medicine

Tongji Hospital

Tongji Medical College

Huazhong University of Science and Technology

Jie Fang Da Dao 1095

430030 Wuhan, China

Tel.: 86-27-83662395


Submit a manuscript:


Changjiang Spatial Information Technology Engineering Co., Ltd. (Wuhan) Hangce Information Cartorgraphy Printing Filial, Wuhan, China

Printed in People's Republic of China